BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

618 related articles for article (PubMed ID: 16192138)

  • 1. The limitations of "vulnerability" as a protection for human research participants.
    Levine C; Faden R; Grady C; Hammerschmidt D; Eckenwiler L; Sugarman J;
    Am J Bioeth; 2004; 4(3):44-9. PubMed ID: 16192138
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rethinking research ethics.
    Rhodes R
    Am J Bioeth; 2005; 5(1):7-28. PubMed ID: 16036651
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Research versus innovation: real differences.
    Morreim H
    Am J Bioeth; 2005; 5(1):42-3; author reply W15-8. PubMed ID: 16036658
    [No Abstract]   [Full Text] [Related]  

  • 4. Does research ethics rest on a mistake?
    Miller FG
    Am J Bioeth; 2005; 5(1):34-6; author reply W15-8. PubMed ID: 16036654
    [No Abstract]   [Full Text] [Related]  

  • 5. How not to rethink research ethics.
    Beauchamp TL
    Am J Bioeth; 2005; 5(1):31-3; author reply W15-8. PubMed ID: 16036653
    [No Abstract]   [Full Text] [Related]  

  • 6. Rethinking research ethics.
    Rhodes R
    Am J Bioeth; 2010 Oct; 10(10):19-36. PubMed ID: 20945264
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Undue inducement: nonsense on stilts?
    Emanuel EJ
    Am J Bioeth; 2005; 5(5):9-13; discussion W8-11, W17. PubMed ID: 16179296
    [No Abstract]   [Full Text] [Related]  

  • 8. An IRB member's perspective on access to innovative therapy.
    Moore DL
    Albany Law Rev; 1994; 57(3):559-81. PubMed ID: 11652854
    [No Abstract]   [Full Text] [Related]  

  • 9. Some questionable premises about research ethics.
    Macklin R
    Am J Bioeth; 2005; 5(1):29-31; author reply W15-8. PubMed ID: 16036652
    [No Abstract]   [Full Text] [Related]  

  • 10. "You may have already won..": an examination of the use of lottery payments in research.
    Brown JS; Schonfeld TL; Gordon BG
    IRB; 2006; 28(1):12-6. PubMed ID: 16680874
    [No Abstract]   [Full Text] [Related]  

  • 11. Vulnerability to influence: a two-way street.
    Henderson GE; Davis AM; King NM
    Am J Bioeth; 2004; 4(3):50-2; discussion W32. PubMed ID: 16192139
    [No Abstract]   [Full Text] [Related]  

  • 12. Waste not, want not: cognitive impairment should not preclude research participation.
    Hougham GW
    Am J Bioeth; 2005; 5(1):36-7; author reply W15-8. PubMed ID: 16036655
    [No Abstract]   [Full Text] [Related]  

  • 13. Ethical issues in international biomedical research: an overview.
    Page AK
    J Health Law; 2004; 37(4):629-65. PubMed ID: 15732566
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A plea for pragmatism in clinical research ethics.
    Brendel DH; Miller FG
    Am J Bioeth; 2008 Apr; 8(4):24-31. PubMed ID: 18576248
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Research in children.
    Burns JP
    Crit Care Med; 2003 Mar; 31(3 Suppl):S131-6. PubMed ID: 12626958
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protecting the vulnerable in brain research.
    Cook-Deegan RM
    Cerebrum; 2000; 2(2):73-91. PubMed ID: 15986545
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical trials in developing countries: who should define ethics?].
    Béréterbide F; Hirsch F
    Bull Soc Pathol Exot; 2008 Apr; 101(2):102-5. PubMed ID: 18543701
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vulnerability: a needed moral safeguard.
    DeMarco JP
    Am J Bioeth; 2004; 4(3):82-4; discussion W32. PubMed ID: 16192156
    [No Abstract]   [Full Text] [Related]  

  • 19. Undue inducement: the only objection to payment?
    VanderWalde A
    Am J Bioeth; 2005; 5(5):25-7. PubMed ID: 16179303
    [No Abstract]   [Full Text] [Related]  

  • 20. Beyond informed consent.
    Bhutta ZA
    Bull World Health Organ; 2004 Oct; 82(10):771-7. PubMed ID: 15643799
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.